Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · ai

Can AI uncover a new path to non-opioid pain relief?

18 August 2026 · By · Wire by Fusion42

Published

18 August 2026

Topic

ai

◆ Sectors

Drug Discovery

◆ Source

Read at drugdiscoverynews.com →

◆ Verified

Fusion42 · 18 August 2026 · Fusion42 review

AI technologies are being leveraged to discover new non-opioid pain relief pathways, aiming to address the opioid crisis by finding safer alternatives.

This Wire brief sits within Fusion42's coverage of Drug Discovery.

◆ ◆ The Wire takeaway

You can now explore AI as a powerful shortcut to identify safer pain relief compounds without opioid risks. This opens a path for biotech founders to pivot drug pipelines towards non-addictive treatments.

◆ Coverage

1 source · 18 Aug 2026

◆ Related on Wire

◆ Topics

Drug Discoveryaidrug-discoverynon-opioidpain-reliefbiotech